Satraplatin (S) demonstrates significant clinical benefits for the treatment of patients with HRPC: Results of a randomized phase III trial.

Reviewer: Eric Shinohara MD, MSCI
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 4 de junio del 2007

Translation for this article does not exist

Blogs

Cancer and Hair Loss
by Bob Riter
February 11, 2016